MEDICAL SCIENTIFIC & TRAINING (DOKTER)

PT Novell Pharmaceutical Laboratories; Jakarta Barat; On-site; IDR 89,280,000 - 133,920,000; Full time

Job summary

Novell Pharmaceutical Laboratories is seeking a qualified Medical Doctor to analyze therapeutics strategies and engage with KOLs alongside the marketing team. The role requires collaboration with sales and product management to enrich team capabilities through scientific presentations and medical information.

The candidate should have 1+ year GP experience, strong analytical and communication skills, a passion for health articles, and fluent English. Placement is in West Jakarta (Head Office).

Qualifications

• Medical Doctor graduated
• Having minimum 1 year experience as General Practitioner in Clinic/Hospital or similar position
• Having good analytical, personal communication and presentation skill
• Interest in writing health articles and disease informations
• Good command in English

Responsibilities

• Analyze and understand therapeutics strategy from books, literature and research journal, and build communication with KOLs together with the marketing team
• Collaborate with multi-function team, such as Sales and Product Management to develop team capabilities through scientific presentation and provide medical information

Skills

Analytical thinking

Communication skills

Presentation skills

English proficiency

Education

Medical Doctor

Job description

Able to analyze and understand about therapeutics strategy from books, literature and research journal

Responsible to build communication with KOL (Key opinion Leaders) along with marketing team

Collaborate with multi-function team, such as Sales and Product Management to develop team capabilities through scientific presentation and provide medical information.

Requirements:

• Medical Doctor graduated


• Having minimum 1 year experience as General Practitioner in Clinic/Hospital or similar position


• Having good analytical, personal communication and presentation skill


• Interest in writing health articles and disease informations


• Good command in English

Placement : West Jakarta (Head Office)

Hirer responsiveness Salary match Number of applicants

Pharmaceuticals, Biotechnology & Medical Devices 1,001-5,000 employees

Novell Pharmaceutical Laboratories was established in 1998 as a consequence of increasing globalisation and trend toward efficiency in the pharmaceutical industry.

After a worldwide merger between pharmaceutical giant Glaxo International and Burroughs Wellcome in 1996, a group of foreign and local investors acquired ex-PT.Burroughs Wellcome manufacturing plant in Indonesia and established a new company, which is called Novell Pharmaceutical Laboratories which has a status as a foreign investment company and registered with Indonesian Coordinating Investment Board (BKPM).

The word Novell comes from an English word Novel that translates as something new, fresh and also brings the meaning of innovation.

In June 2011, Novell obtained its approval from Australian Therapeutic Goods Administration (TGA), in 2009 from GCC, in 2009 from South Africa MCC, in 2009 from UAE, in 2010 from Kenya and in 2011 from Turkey as a proof of its constant improvement in its quality process to ensure quality products for all its customers.

In 2013, Novell Pharma becomes the first Indonesian local pharma company to obtain GMP approval from European Union authority (Germany - Lageso) for its injectable plant. Novell also becomes the only company to have GMP license from Europe, Australia, South Africa PICS and GCC Gulf Countries.

As part of its international expansion, Novell has its own office and marketing team in the Philippines, Thailand and Vietnam, with more than 30 employees outside Indonesia.

Novell Pharmaceutical Laboratories was established in 1998 as a consequence of increasing globalisation and trend toward efficiency in the pharmaceutical industry.

After a worldwide merger between pharmaceutical giant Glaxo International and Burroughs Wellcome in 1996, a group of foreign and local investors acquired ex-PT.Burroughs Wellcome manufacturing plant in Indonesia and established a new company, which is called Novell Pharmaceutical Laboratories which has a status as a foreign investment company and registered with Indonesian Coordinating Investment Board (BKPM).

The word Novell comes from an English word Novel that translates as something new, fresh and also brings the meaning of innovation.

In June 2011, Novell obtained its approval from Australian Therapeutic Goods Administration (TGA), in 2009 from GCC, in 2009 from South Africa MCC, in 2009 from UAE, in 2010 from Kenya and in 2011 from Turkey as a proof of its constant improvement in its quality process to ensure quality products for all its customers.

In 2013, Novell Pharma becomes the first Indonesian local pharma company to obtain GMP approval from European Union authority (Germany - Lageso) for its injectable plant. Novell also becomes the only company to have GMP license from Europe, Australia, South Africa PICS and GCC Gulf Countries.

As part of its international expansion, Novell has its own office and marketing team in the Philippines, Thailand and Vietnam, with more than 30 employees outside Indonesia.